Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
Nat Microbiol ; 9(2): 377-389, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38263454

ABSTRACT

Buruli ulcer, a chronic subcutaneous infection caused by Mycobacterium ulcerans, is increasing in prevalence in southeastern Australia. Possums are a local wildlife reservoir for M. ulcerans and, although mosquitoes have been implicated in transmission, it remains unclear how humans acquire infection. We conducted extensive field survey analyses of M. ulcerans prevalence among mosquitoes in the Mornington Peninsula region of southeastern Australia. PCR screening of trapped mosquitoes revealed a significant association between M. ulcerans and Aedes notoscriptus. Spatial scanning statistics revealed overlap between clusters of M. ulcerans-positive Ae. notoscriptus, M. ulcerans-positive possum excreta and Buruli ulcer cases, and metabarcoding analyses showed individual mosquitoes had fed on humans and possums. Bacterial genomic analysis confirmed shared single-nucleotide-polymorphism profiles for M. ulcerans detected in mosquitoes, possum excreta and humans. These findings indicate Ae. notoscriptus probably transmit M. ulcerans in southeastern Australia and highlight mosquito control as a Buruli ulcer prevention measure.


Subject(s)
Aedes , Buruli Ulcer , Mycobacterium ulcerans , Animals , Humans , Buruli Ulcer/epidemiology , Buruli Ulcer/genetics , Buruli Ulcer/microbiology , Mycobacterium ulcerans/genetics , Australia , Genome, Bacterial , Aedes/genetics
3.
Article in English | MEDLINE | ID: mdl-33349204

ABSTRACT

ABSTRACT: Laboratory-confirmed infection with Mycobacterium ulcerans is currently notifiable to health departments in several jurisdictions. Accurate surveillance is imperative to understanding current and emerging areas of endemicity and to facilitate research into a neglected tropical disease with poorly-understood transmission dynamics. The state of Victoria currently reports some of the highest numbers of M. ulcerans cases in the world each year, with 340 cases notified in 2018 (an incidence of 5.5 per 100,000 population). In May 2019, a group of clinical, laboratory and public health experts met to discuss a new case definition for the surveillance of M. ulcerans disease in Victoria, incorporating clinical and epidemiological elements. The new case definition supports important public health messaging and actions for residents and visitors to popular tourist areas in Victoria.


Subject(s)
Buruli Ulcer/diagnosis , Buruli Ulcer/epidemiology , Neglected Diseases/diagnosis , Neglected Diseases/epidemiology , Population Surveillance , Buruli Ulcer/pathology , Disease Notification , Humans , Incidence , Mycobacterium ulcerans/isolation & purification , Neglected Diseases/pathology , Polymerase Chain Reaction , Victoria/epidemiology
4.
Emerg Infect Dis ; 24(11): 1988-1997, 2018 11.
Article in English | MEDLINE | ID: mdl-30334704

ABSTRACT

Buruli ulcer (BU) is a destructive soft-tissue infection caused by the environmental pathogen Mycobacterium ulcerans. In response to rising BU notifications in the state of Victoria, Australia, we reviewed all cases that occurred during 2011-2016 to precisely map the time and likely place of M. ulcerans acquisition. We found that 600 cases of BU had been notified; just over half were in residents and the remainder in visitors to defined BU-endemic areas. During the study period, notifications increased almost 3-fold, from 66 in 2013 to 182 in 2016. We identified 4 BU-endemic areas: Bellarine Peninsula, Mornington Peninsula, Frankston region, and the southeastern Bayside suburbs of Melbourne. We observed a decline in cases on the Bellarine Peninsula but a progressive increase elsewhere. Acquisitions peaked in late summer. The appearance of new BU-endemic areas and the decline in established areas probably correlate with changes in the level of local environmental contamination with M. ulcerans.


Subject(s)
Buruli Ulcer/epidemiology , Endemic Diseases , Mycobacterium ulcerans/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Buruli Ulcer/drug therapy , Buruli Ulcer/microbiology , Child , Child, Preschool , Demography , Female , Geography , Humans , Incidence , Infant , Male , Middle Aged , Mycobacterium ulcerans/genetics , Victoria/epidemiology , Young Adult
5.
Med J Aust ; 204(8): 320, 2016 May 02.
Article in English | MEDLINE | ID: mdl-27125809

ABSTRACT

OBJECTIVE: To quantify absolute cardiovascular disease (CVD) risk and treatment in Australian adults. DESIGN, PARTICIPANTS: Cross-sectional representative study of 9564 people aged 18 years or more who had participated in the 2011-12 Australian National Health Measures Survey (response rate for those aged 45-74 years: 46.5%). MAIN OUTCOME MEASURES: Prior CVD was ascertained and 5-year absolute risk of a primary CVD event calculated (using the Australian National Vascular Disease Prevention Alliance algorithm; categories: low [< 10%], moderate [10-15%], and high [> 15%] risk) on the basis of data on medical history, risk factors and medications, derived from interviews, physical measurements, and blood and urine samples. RESULTS: Absolute CVD risk increased with age and was higher among men than women. Overall, 19.9% (95% CI, 18.5-21.3%) of Australians aged 45-74 years had a high absolute risk of a future CVD event (an estimated 1 445 000 people): 8.7% (95% CI, 7.8-9.6%) had prior CVD (estimated 634 000 people) and 11.2% (95% CI, 10.2-12.2%) had high primary CVD risk (estimated 811 000 people). A further 8.6% (95% CI, 7.4-9.8%, estimated 625 000) were at moderate primary CVD risk. Among those with prior CVD, 44.2% (95% CI, 36.8-51.6%) were receiving blood pressure- and lipid-lowering medications, 35.4% (95% CI, 27.8-43.0%) were receiving only one of these, and 20.4% (95% CI, 13.9-26.9%) were receiving neither. Corresponding figures for high primary CVD risk were 24.3% (95% CI, 18.3-30.3%); 28.7% (95% CI, 22.7-34.7%); and 47.1% (95% CI, 39.9-54.3%). CONCLUSIONS: About one-fifth of the Australian population aged 45-74 years (about 1.4 million individuals) were estimated to have a high absolute risk of a future CVD event. Most (estimated 970 000) were not receiving currently recommended combination blood pressure- and lipid-lowering therapy, indicating substantial potential for health gains by increasing routine assessment and treatment according to absolute CVD risk.


Subject(s)
Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/prevention & control , Hypertension/epidemiology , Hypertension/prevention & control , Hypolipidemic Agents/therapeutic use , Practice Patterns, Physicians'/standards , Adult , Age Distribution , Aged , Antihypertensive Agents/therapeutic use , Australia , Cross-Sectional Studies , Family Practice , Female , Humans , Male , Middle Aged , Risk Assessment , Risk Management , Sex Distribution
6.
BMC Public Health ; 14: 635, 2014 Jun 21.
Article in English | MEDLINE | ID: mdl-24952766

ABSTRACT

BACKGROUND: It has been suggested that children with same-sex attracted parents score well in psychosocial aspects of their health, however questions remain about the impact of stigma on these children. Research to date has focused on lesbian parents and has been limited by small sample sizes. This study aims to describe the physical, mental and social wellbeing of Australian children with same-sex attracted parents, and the impact that stigma has on them. METHODS: A cross-sectional survey, the Australian Study of Child Health in Same-Sex Families, was distributed in 2012 to a convenience sample of 390 parents from Australia who self-identified as same-sex attracted and had children aged 0-17 years. Parent-reported, multidimensional measures of child health and wellbeing and the relationship to perceived stigma were measured. RESULTS: 315 parents completed the survey (completion rate = 81%) representing 500 children. 80% of children had a female index parent while 18% had a male index parent. Children in same-sex parent families had higher scores on measures of general behavior, general health and family cohesion compared to population normative data (ß = 2.93, 95% CI = 0.35 to 5.52, P = .03; ß = 5.60, 95% CI = 2.69 to 8.52, P = <.001; and ß = 6.01, 95% CI = 2.84 to 9.17, P = <.001 respectively). There were no significant differences between the two groups for all other scale scores. Physical activity, mental health, and family cohesion were all negatively associated with increased stigma (ß = -3.03, 95% CI = -5.86 to -0.21, P = .04; ß = -10.45, 95% CI = -18.48 to -2.42, P = .01; and ß = -9.82, 95% CI = -17.86 to -1.78, P = .02 respectively) and the presence of emotional symptoms was positively associated with increased stigma (ß =0.94, 95% CI = 0.08 to 1.81, P = .03). CONCLUSIONS: Australian children with same-sex attracted parents score higher than population samples on a number of parent-reported measures of child health. Perceived stigma is negatively associated with mental health. Through improved awareness of stigma these findings play an important role in health policy, improving child health outcomes.


Subject(s)
Child Welfare , Emotions , Health , Homosexuality , Parents , Social Stigma , Adolescent , Australia/epidemiology , Child , Child Behavior , Child Welfare/statistics & numerical data , Child, Preschool , Cross-Sectional Studies , Data Collection , Family , Female , Humans , Infant , Infant, Newborn , Male , Mental Health , Parents/psychology , Personal Satisfaction
8.
Aust Health Rev ; 36(1): 57-60, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22513021

ABSTRACT

OBJECTIVE: Chlamydia prevention and control form a significant part of the Australian Government's sexual health policy. This paper examines the evidence for policy development and in particular the role of systematic reviews in evidence-based policy. METHODS: The author undertook a review of the literature on evidence-based policy. The major theories for evidence-based policy were then linked to the Australian Government's main chlamydia policy. RESULTS: A systematic review on chlamydia screening has been influential in policy development, but like all systematic reviews its validity must be assessed. It has been suggested that methodological appropriateness and the question being asked are perhaps more important than study design per se. Partnerships between researchers and policymakers are important but it should be noted that experts have their own particular biases. Policymaking can also be determined by political ideologies. CONCLUSIONS AND IMPLICATIONS: The publication of a systematic review has provided a good summative evaluation of chlamydia screening that has been built upon through partnerships with researchers. The resulting chlamydia screening pilot will provide further evidence for future policy; however, a variety of sources are required to develop robust policy directions.


Subject(s)
Chlamydia Infections/diagnosis , Evidence-Based Medicine , Mass Screening/organization & administration , Australia , Chlamydia/isolation & purification , Chlamydia Infections/prevention & control , Health Policy , Humans , Pilot Projects , Policy Making
SELECTION OF CITATIONS
SEARCH DETAIL
...